So many companies are shifting their employees to working from home to address the Covid-19 coronavirus pandemic. Yet they’re not considering the potential quality disasters that can occur as a result of this transition.
Each article in this series presents new tools for increasing return on investment, enhancing customer satisfaction, creating process excellence, and driving risk from an ISO 9001:2015-based quality management system.
Historically, risk management has been a complex and polarizing subject, with various stakeholders assigning different values on the probability and severity of harm.
Nuclear power has long been a clean, dependable source of energy throughout the world. However, as power plants age, concerns grow about their continued reliability.
As shelter-in-place orders make work-from-home (WFH) the new normal, some organizations are struggling with the transition to working as a remote team.
Long stretches of empty supermarket shelves and shortages of essential supplies are only the visible impacts to consumers of the global supply-chain disruption caused by the Covid-19 pandemic.
We [Alan Rudolph and Raymond Goodrich] are both biotechnology researchers and are currently seeking to repurpose an existing medical manufacturing platform to quickly develop a vaccine candidate for Covid-19.
Even in the midst of the pandemic, product safety and quality remain critical. For many manufacturers, complex quality management systems and procedures stand in the way of agile responses and effective operational optimization.
The labor market is changing rapidly with the onset of the coronavirus pandemic.
The amount of risk that one is exposed to when running a business is vast. Some risks may result in severe legal or financial trouble or cause the business to shut down. Mitigating these risks is a major aspect of successfully running a business.